Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Family Practice · SIOUX FALLS, SD · NPI 1306892633
Verified facts
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
We did not find matching Open Payments records for this doctor in the selected program year.
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 438 | 129 |
| Omeprazole | Omeprazole | 411 | 112 |
| Levothyroxine Sodium | Levothyroxine Sodium | 331 | 97 |
| Amlodipine Besylate | Amlodipine Besylate | 245 | 71 |
| Losartan Potassium | Losartan Potassium | 227 | 58 |
| Meloxicam | Meloxicam | 171 | 51 |
| Gabapentin | Gabapentin | 169 | 42 |
| Lisinopril | Lisinopril | 169 | 50 |
| Tamsulosin Hcl | Tamsulosin Hcl | 168 | 52 |
| Metoprolol Succinate | Metoprolol Succinate | 167 | 52 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 160 | 50 |
| Metformin Hcl | Metformin Hcl | 158 | 41 |
| Sertraline Hcl | Sertraline Hcl | 155 | 39 |
| Hydrochlorothiazide | Hydrochlorothiazide | 146 | 47 |
| Potassium Chloride | Potassium Chloride | 132 | 46 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 121 | 32 |
| Trazodone Hcl | Trazodone Hcl | 121 | 31 |
| Pantoprazole Sodium | Pantoprazole Sodium | 120 | 23 |
| Metoprolol Tartrate | Metoprolol Tartrate | 117 | 35 |
| Simvastatin | Simvastatin | 115 | 39 |
| Clonazepam | Clonazepam | 101 | 26 |
| Glipizide | Glipizide | 101 | 27 |
| Allopurinol | Allopurinol | 97 | 29 |
| Furosemide | Furosemide | 90 | 29 |
| Atenolol | Atenolol | 86 | 22 |
| Alendronate Sodium | Alendronate Sodium | 83 | 24 |
| Eliquis | Apixaban | 76 | 21 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 75 | 15 |
| Tramadol Hcl | Tramadol Hcl | 74 | 16 |
| Fenofibrate | Fenofibrate | 72 | 14 |
| Duloxetine Hcl | Duloxetine Hcl | 66 | 16 |
| Donepezil Hcl | Donepezil Hcl | 62 | 16 |
| Clopidogrel | Clopidogrel Bisulfate | 59 | 21 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 56 | 25 |
| Montelukast Sodium | Montelukast Sodium | 50 | 13 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 47 | 11 |
| Finasteride | Finasteride | 46 | 16 |
| Fluoxetine Hcl | Fluoxetine Hcl | 46 | 14 |
| Warfarin Sodium | Warfarin Sodium | 43 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 42 | 14 |
| Citalopram Hbr | Citalopram Hydrobromide | 41 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 41 | 12 |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 40 | suppressed |
| Carvedilol | Carvedilol | 39 | suppressed |
| Ezetimibe | Ezetimibe | 39 | 15 |
| Pioglitazone Hcl | Pioglitazone Hcl | 39 | suppressed |
| Jardiance | Empagliflozin | 36 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 35 | 18 |
| Cephalexin | Cephalexin | 35 | 13 |
| Latanoprost | Latanoprost | 35 | suppressed |
| Glipizide Er | Glipizide | 33 | suppressed |
| Ozempic | Semaglutide | 33 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 33 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 32 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 32 | 12 |
| Spironolactone | Spironolactone | 32 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 30 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 29 | 25 |
| Zolpidem Tartrate | Zolpidem Tartrate | 29 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 28 | suppressed |
| Prednisone | Prednisone | 27 | 21 |
| Diazepam | Diazepam | 26 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 26 | 22 |
| Bupropion Xl | Bupropion Hcl | 24 | suppressed |
| Synthroid | Levothyroxine Sodium | 24 | suppressed |
| Digoxin | Digoxin | 23 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 23 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 22 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 22 | suppressed |
| Xarelto | Rivaroxaban | 22 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 21 | suppressed |
| Calcitriol | Calcitriol | 20 | suppressed |
| Famotidine | Famotidine | 20 | suppressed |
| Nitroglycerin | Nitroglycerin | 20 | 17 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 20 | suppressed |
| Alprazolam | Alprazolam | 19 | suppressed |
| Clotrimazole | Clotrimazole | 19 | suppressed |
| Lansoprazole | Lansoprazole | 19 | suppressed |
| Mirtazapine | Mirtazapine | 19 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 19 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 18 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 18 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 17 | suppressed |
| Estradiol | Estradiol | 17 | suppressed |
| Carbamazepine | Carbamazepine | 16 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 16 | suppressed |
| Nifedipine Er | Nifedipine | 16 | suppressed |
| Acyclovir | Acyclovir | 15 | suppressed |
| Brilinta | Ticagrelor | 15 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 15 | suppressed |
| Januvia | Sitagliptin Phosphate | 15 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 15 | suppressed |
| Pregabalin | Pregabalin | 15 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 15 | 14 |
| Valacyclovir | Valacyclovir Hcl | 15 | suppressed |
| Amoxicillin | Amoxicillin | 14 | 11 |
| Piroxicam | Piroxicam | 14 | suppressed |
| Entacapone | Entacapone | 13 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 13 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 13 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 12 | suppressed |
| Carbamazepine Er | Carbamazepine | 12 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 12 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 12 | suppressed |
| Lorazepam | Lorazepam | 12 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 12 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 12 | suppressed |
| Chlorthalidone | Chlorthalidone | 11 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 11 | suppressed |
| Linzess | Linaclotide | 11 | suppressed |
| Myrbetriq | Mirabegron | 11 | suppressed |
| Ondansetron Odt | Ondansetron | 11 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 11 | suppressed |
| Verapamil Er | Verapamil Hcl | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error